<DOC>
	<DOC>NCT00723736</DOC>
	<brief_summary>The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.</brief_summary>
	<brief_title>Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)</brief_title>
	<detailed_description>Pediatric patients aged 1-5 years</detailed_description>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Patients with allergic rhinitis or chronic idiopathic urticaria Aged 15 years old Caregiver's consent to participate Healthy individuals Younger or older than the 15 year old age range</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>